D-amino Acid Market

The D-amino acid market may observe a profitable forecast period on the back of increasing demand for domestic and synthetic peptides and peptide-based drugs. The use of D-amino acids in the aforementioned products may bring considerable growth for the D-amino acid market. Based on product, the D-amino acid market can be segmented into D-Alanine, D-Glutamic Acid, D-Aspartic Acid, D-Methionine, D-Threonine, D-Tryptophan, D-Leucine, D-Phenylalanine, D-Valine, and Others (D-Histidine, D-Proline, D-Serine, etc.)

The COVID-19 outbreak has caused havoc and tremendous losses have been incurred by businesses across the world. The D-amino acid market may not have a massive negative impact of the novel coronavirus outbreak as the pharmaceutical sector is open in full force in the lockdown period also.

• D-amino acid has various benefits such as improved exercise performance, promotes weight loss, improves mood, and prevents muscle loss. The rising concerns about health coupled with the associated advantages may invite good growth opportunities for the D-amino acid market.
• The use of D-amino acids with diverse amino acid types is on the rise. The sizeable demand for D-amino acid from research centers and laboratories leads to a surge in the growth rate of the D-amino acid market. The biosynthesis sector also acts as a growth generator for the D-amino acid market.
• Many companies operate across the D-amino acid market and strengthen their base through activities like mergers, acquisitions, partnerships, and joint ventures. Key players involved in the D-amino acid market are Tokyo Chemical Industry, Evonik Industries AG, Sekisui Medical Co. Ltd., AnaSpec Inc., and Central Drug House Pvt Ltd.
• Asia Pacific may serve as an important growth generating region for the D-amino acid market. Asia Pacific has a considerable number of processors and manufacturers relating to pharmaceutical industries. This region may continue to hold a significant market share in the near future due to the aforementioned factors.

D-amino Acid Market - Snapshot

Amino acids are compounds whose molecules encompass amine group (-NH2) and carboxyl group (-COOH). D-amino acid is a class of unnatural amino acids. It is a constituent of natural peptides produced primarily by microorganisms, using the non-ribosomal mechanism of synthesis. D-amino acid is a component of certain peptide antibiotics and is present in walls of certain microorganisms. D-amino acids are chiral form of L-amino acids. They are widely used in pharmaceutical synthesis (medicine and pesticides), food, animal feed, etc. The global D-amino acid market is expected to expand at a significant pace during the forecast period, driven by the increase in demand for D-amino acid in the pharmaceutical industry. The global D-amino acid market was valued at around US$ 150.0 Mn in 2017 and is anticipated to expand at a CAGR of more than 5.0% from 2018 to 2026.

D-amino acid plays an important role in vital processes of the human body such as tissue growth, energy production, immune function, and nutrient absorption. D-tryptophan is used to produce serotonin that regulates mood, sleep, and human behavior. D-amino acid alleviates fatigue, improves athletic performance, and stimulates muscle recovery. It assists in preventing muscle breakdown and preserving lean body mass. D-amino acid also improves mood, boosts exercise performance, prevents muscle loss, and promotes weight loss.  D-amino acid provides health benefits. Therefore, demand for D-amino acid is estimated to increase in the next few years. Rise in awareness about health concerns and changes in lifestyle trends are likely to boost the global D-amino acid market.

D-amino acid is primarily used in the production of domestic & synthetic peptides and peptide-based drugs. These D-amino based peptides possess synthetizing characteristics and are used in the treatment of Alzheimer's disease and tumors. D-amino based peptides are also used in synthetic peptide anti-pain analgesics and synthetic peptide protease inhibitors in keratotomy. These acids enable early detection of the Alzheimer's disease. Thus, increase in production of peptides in pharmaceutical applications is projected to boost the demand for D-amino acid. D-amino acid is also employed in synthesis of nicotinamide acetylcholine receptors, calcium channels, sodium channels, anti-epilepsy drugs, and endorphin releasing drugs. High prevalence of chronic diseases and the need to diagnose and treat such diseases in anticipated to augment the demand for d-amino acids during the forecast period. Peptides containing D-amino acids are used as sweeteners in the food & beverages industry. D-amino acid is used in therapeutic agents for atopic dermatitis, skin moisturizers, and wrinkle formation inhibitors. It is also used as skin beautifying agent in the cosmetics industry.

Asia Pacific is a major region of the d-global amino acid market, accounting for substantial share. China is a key producer and consumer of D-amino acid. Presence of large number of manufacturers and processors in the pharmaceutical industry is expected to drive the D-amino acid market in Asia Pacific. Rapid industrialization and expansion of pharmaceutical manufacturing and processing plants in China and Japan are projected to provide an impetus to the demand for D-amino acid in these countries. Demand for D-amino acids in the U.S. is projected to increase owing to the rise in research activities in D-amino acids and their production techniques. North America and Europe are the major hubs for the manufacture and processing of food and beverages. The D-amino acid market in Europe is estimated to expand at a moderate pace during the forecast period.

Major players operating in the D-amino acid market include Evonik Industries AG, Tokyo Chemical Industry Co., Ltd., YONEYAMA YAKUHIN KOGYO CO., LTD, Central Drug House (P) Ltd., Zhangjiagang Huachang Pharmaceutical Co. Ltd., Sichuan Tongsheng Amino acid Co., Ltd, Sekisui Medical Co. Ltd, Kyowa Hakkon Kirin Co. Ltd, AnaSpec, Inc., and Varsal Chemicals. These players are focusing on reinforcing their D-amino acid product lines in order to increase their market share.